CSN Login
Members Online: 1

You are here

Coronavirus/COVID-19

What cancer patients, their families, and caregivers need to know about COVID-19.

Announcements

Have an announcement? Complete and submit an announcement submission request form. Announcements are selected based on relevance and available space. Selection does not imply endorsement by the American Cancer Society.

Wednesday, March 18, 2020 - 9:46am

Event (e.g.conference, teleconference, fundraiser, etc.)

Wednesday, March 18, 2020 - 9:45am
Free Upcoming CancerCare Connect® Education Workshops

Free Upcoming CancerCare Connect® Education Workshops

CancerCare workshops take place over the telephone or as a webcast online.

www.cancercare.org/connect 

 

CancerCare, in collaboration with the American Cancer Society, offers free workshops on a variety of cancer-related topics. Unless otherwise noted, all workshops take place from 1:30 - 2:30 pm Eastern Time. For details and to register for a workshop, call 800-813-HOPE (4673), or visit the CancerCare website at www.cancercare.org/connect 

 

3/18 – Understanding the Costs of Care and Your Health Care Coverage, Part II of Life with Cancer: A Guide to Getting the Best Care

3/19 – The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)

3/20 – New Perspectives in Clinical Trial Research

3/24 – Taking Your Blood Cancer Treatment on Schedule

3/25 – Cancer and the Workplace: Understanding Your Legal Protection, Part III of Life with Cancer: A Guide to Getting the Best Care

3/27 – Updates on the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

3/30 – The New Coronavirus (COVID-19): Guidelines for People Coping with Cancer

4/8 – Participating in Decisions about Your Care, Part IV of Life with Cancer: A Guide to Getting the Best Care

4/9 – Update on Chronic Lymphocytic Leukemia, Part I of Life with Chronic Lymphocytic Leukemia (CLL) (4:00 – 5:00 PM Eastern Time)

4/13 – Advances in the Treatment of Gastric Cancer

4/14 – Caregiving for Your Loved One with Cancer

4/15 – What’s New in the Treatment of Oral and Head and Neck Cancer

4/16 – Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)

4/22 – For Caregivers: Care Coordination for Your Loved One Living with Cancer and Other Health Problems, Part V of Life with Cancer: A Guide to Getting the Best Care

4/23 – Update on Glioblastoma in Adults

4/30 – Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

4/30 – Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL), Part II of Life with Chronic Lymphocytic Leukemia (CLL) (4:00 – 5:00 PM Eastern Time)

For more information, contact:
Lorena Tan Wan
800-813-HOPE (4673)
connect@cancercare.org
Tuesday, March 17, 2020 - 8:47am

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Monday, March 16, 2020 - 3:15pm

As an individual with a personal history of cancer, you are invited to participate in a brief survey being conducted by the American Society of Clinical Onocology to learn more about patients’ experiences with cancer care. More specifically, we hope to learn how topics like diet, exercise and weight management are incorporated into cancer care.  The survey should take no more than 10-minutes to complete.  Please note no personally identifiable information will be collected, and all questions are optional to complete. Thank you for your assistance in helping ASCO to improve cancer care.    

 

Survey Link: https://www.surveymonkey.com/r/ASCODEWM?ch=CSN

 

 

For more information, contact:
Janette Merrill
5714831629
janette.merrill@asco.org
Thursday, October 17, 2019 - 2:23pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Thursday, October 17, 2019 - 1:00pm

The Laboratory for Brain and Cognitive Health Technology at McLean Hospital is collaborating with the National Cancer Institute to implement a study looking at cognition in those who have been affected by cancer.

The study takes about an hour and includes completing 2 questionnaires about your background and then completing 12 cognitive tasks that look at your attention and cognitive style. At the end, you will get your scores on these tests and how they compare to others who have completed the same tests.

Eligibility:

1) We are seeking women and men who have a current or past diagnosis of cancer between the ages of 18 and 89.

2) However, you cannot be currently receiving treatment for cancer (e.g. surgery, chemotherapy, radiation therapy, or hormonal therapy etc.)

Benefits:

You will receive no direct benefits from your participation in this study. However, you will be given feedback on your performance on the tests at the end of the study. In addition, we hope this study will provide information that will further cancer researchers’ understanding of cognition in cancer affected individuals and appropriate tests to use to examine brain health in people who have had cancer.

Contact Person:

If you have any questions about this study or your eligibility, please email: bachtech@mclean.harvard.edu . Please mention "Cancer Study" in your message.

To participate in this study, please follow this link:

https://testmybrain.org/launch/nci_bridgestudy/NCIentry.php?g=a

 

 

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

 

 

For more information, contact:
Todd Horowitz
2402766963
todd.horowitz@nih.gov
Wednesday, May 15, 2019 - 10:23pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Friday, May 15, 2020 - 10:15pm

Maurade Gormley is conducting breast cancer survivorship research funded by the National Institutes of Health at New York University Rory Meyers College of Nursing to better understand how Oncotype Dx® test results may influence health-related quality of life, distress, anxiety, depression, fear, and perceived risk of breast cancer recurrence. If you’ve received the Oncotype Dx® test and are willing to answer a series of questionnaires about your reaction to the test, please contact Maurade Gormley at (203) 767-6653 or via email at mh1847@nyumc.org to discuss eligibility and informed consent. Questionnaires will take approximately 15 to 30 minutes. You will receive a link to the questionnaires to complete online. You may be asked to participate in a telephone interview on a future date. The interview is voluntary. Thank you!

For more information, contact:
Maurade  Gormley
2037676653
mh1847@nyumc.org
Monday, September 17, 2018 - 6:15pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Monday, September 17, 2018 - 6:00pm
Lauren Loughlin

The Association of Stigma and Self-Disclosure with Social Support, Mental Health, and Posttraumatic Growth Among Cancer Patients

This study examines experiences of living with cancer. You are being asked to complete a series of questionnaires that assess your experiences of stigma, self-disclosure, social support seeking and utilization, and mental health. In order to better understand how people experience cancer, we are interested in hearing the voices of cancer survivors. You will qualify for the study if you are 18 years old or older, have been diagnosed with any type of cancer six to eighteen months prior to participation in the study, and are currently post-treatment. The entire study will take about 45 minutes to complete. Your participation is completely voluntary and if you are uncomfortable at any time, you are welcome to stop answering the questions. Upon completing the survey, you will have the opportunity to voluntarily provide your email address in order to enter a drawing to win a $100 Amazon gift card.

Thank you for considering your participation. The study is confidential.
Please feel free to send this study to others who may qualify.
We appreciate your time.

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study. We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study. Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Lauren Loughlin
8457051619
laurenloughlin@mail.adelphi.edu
Friday, July 20, 2018 - 12:23pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Friday, July 20, 2018 - 12:15pm

Purpose: The American Cancer Society is testing a modified version of the Cancer Survivors Network (CSN) and is inviting you to try it. This research is being done in collaboration with Carnegie Mellon University and is sponsored by the National Institutes of Health.

 

Procedure: Your participation is voluntary.  If you agree, you will use a modified version of CSN to participate in the community.  You will have access to all CSN content, and any posts or comments you make will be added to the CSN community, just as they are now. What is new is that you will see recommendations for content and other members that might interest you. These recommendations are based on what you have read on CSN. As you read more discussion threads, the recommended content and members will be updated. You will occasionally receive a survey to get your feedback on the new interface. We will also ask about the relevance and value of the recommended content.   These surveys will take less than three minutes to complete, and you will receive them at most once per week. We will also invite a small number of members to give more extensive feedback through a phone interview.

 

To participate in this trial, click this link: Yes, I’ll use the new CSN interface.  You can always opt-out later by clicking ‘the use the traditional CSN design’ button on your CSN user profile.

 

Principal investigators:

Robert Kraut, PhD

Herbert A. Simon Professor of Human-Computer Interaction

Carnegie Mellon University

Pittsburgh PA 15213

412 268-7694

robert.kraut@cmu.edu

 

Tenbroeck Smith

Director of Patient Reported Outcomes Research, Behavioral Research Center

American Cancer Society

Atlanta GA

 

tenbroeck.smith@cancer.org

For more information, contact:
Robert Kraut
(412) 268-7694
robert.kraut@cmu.edu